These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 4751259)
21. Combination therapy: some concepts and results. Skipper HE Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649 [No Abstract] [Full Text] [Related]
22. Antitumor activity and pharmacologic disposition of cytosine arabinoside (NSC-63878). Dixon RL; Adamson RH Cancer Chemother Rep; 1965 Oct; 48():11-6. PubMed ID: 5834734 [No Abstract] [Full Text] [Related]
23. Further considerations in the therapy with ara-C. Kreis W Ann N Y Acad Sci; 1975 Aug; 255():244-6. PubMed ID: 1059359 [No Abstract] [Full Text] [Related]
24. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia. Schmid FA; Hutchison DJ; Otter GM; Stock CC Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516 [TBL] [Abstract][Full Text] [Related]
25. [Personal experience with the treatment of infantile acute leukemia with cytosine-arabinoside]. Massolo F; Bertolani MF; Galli V; Tamborino G Minerva Pediatr; 1976 Nov; 28(37):2297-302. PubMed ID: 1004416 [No Abstract] [Full Text] [Related]
26. Combination chemotherapy with cytosine arabinoside, L-asparaginase, and 6-azauridine for transplantable murine leukemias. Avery TL; Roberts D Cancer Res; 1973 Apr; 33(4):791-9. PubMed ID: 4696479 [No Abstract] [Full Text] [Related]
27. Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962). Kline I; Woodman RJ; Gang M; Cysyk RL; Venditti JM Cancer Chemother Rep; 1973; 57(3):291-8. PubMed ID: 4751255 [No Abstract] [Full Text] [Related]
28. Studies of the L1210 antileukemic activity of O-2,2'-cyclocytidine, monoacetate (anhydro-ara-C; NSC-129220)--comparison with cytosine arabinoside (NSC-63878) with respect to treatment schedule dependency. Venditti JM; Baratta MC; Greenberg NH; Abbott BJ; Kline I Cancer Chemother Rep; 1972 Aug; 56(4):483-92. PubMed ID: 5081591 [No Abstract] [Full Text] [Related]
30. Substances with antineoplastic activity. XCVI. Some pharmacological properties and therapeutic synergism of 6-purinyl-N-(2-chloroethyl)thiocarbamate with cytosine arabinoside. Mĕlka M; Krepelka J; Miko M; Pokorná S; Kejhová I; Reichlová R; Beitová M; Grimová J; Kargerová A; Sedivá J Neoplasma; 1989; 36(4):419-25. PubMed ID: 2671756 [TBL] [Abstract][Full Text] [Related]
31. Combined effect of cytosine arabinoside and thiopurines. Valeriote F; Vietti T; Edelstein M Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347 [TBL] [Abstract][Full Text] [Related]
32. Lack of activity of beta-2'-deoxythioguanosine against two tumors resistant to 6-thioguanine. Nelson JA; Kuhns JN; Carpenter JW Cancer Res; 1975 May; 35(5):1372-4. PubMed ID: 1168098 [No Abstract] [Full Text] [Related]
33. Combination chemotherapy with cyclophosphamide (NSC-26271), cytosine arabinoside (NSC-63878), and methotrexate (NSC-740) in advanced solid tumors. Odujinrin OO; DeConti RC; Bertino JR Cancer Chemother Rep; 1975; 59(6):1091-6. PubMed ID: 769948 [TBL] [Abstract][Full Text] [Related]
34. Biochemical aspects of drug combinations. Brockman RW Cancer Chemother Rep 2; 1974 Mar; 4(1):115-29. PubMed ID: 4135108 [No Abstract] [Full Text] [Related]
35. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia. Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790 [No Abstract] [Full Text] [Related]
36. [Results of cytarabine and 6-thioguanine combination chemotherapy in acute leukemia]. Drings P; Fritsch H; von Kaick G; Moskwa G; Sefrin R Verh Dtsch Ges Inn Med; 1973; 79():353-5. PubMed ID: 4524456 [No Abstract] [Full Text] [Related]
37. Combination chemotherapy for acute nonlymphoblastic leukemia in adults. Glucksberg H; Buckner CD; Fefer A; DeMarsh Q; Coleman D; Dobrow RB; Huff J; Kjobech C; Hill AS; Dittman W; Neiman PE; Cheever MA; Einstein AB; Thomas ED Cancer Chemother Rep; 1975; 59(6):1131-7. PubMed ID: 769952 [TBL] [Abstract][Full Text] [Related]
38. [6-Thioguanine in the chemotherapy of leukemias]. Zidermane AA Vopr Onkol; 1979; 25(1):74-83. PubMed ID: 284664 [No Abstract] [Full Text] [Related]
39. Study of cytosine arabinoside (NSC-63878) synchronization plus vincristine (NSC-67574), prednisone (NSC-10023), and L-asparaginase (NSC-109229) for remission induction in advanced acute leukemia in children. Sutow WW; Thomas D; Steuber CP; Pullen J; Vats T; Bryan JH; Morgan SK Cancer Treat Rep; 1976 May; 60(5):591-4. PubMed ID: 991148 [TBL] [Abstract][Full Text] [Related]
40. [Preliminary results of cytosine arabinoside therapy in various chemotherapeutic combinations in acute leukemias]. Fontana G; Rizzo SC; Barosi G Haematologica; 1972; 57(7):389-96. PubMed ID: 4628585 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]